Re-engineering of Pathogenic Aquaporin 4-Specific Antibodies as Molecular Decoys to Treat Neuromyelitis Optica
ANNALS OF NEUROLOGY (2012)
作者
我是这篇论文的作者
推荐
Neuromyelitis Optica Spectrum Disorder
Dean M. Wingerchuk, Claudia F. Lucchinetti
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Neuromyelitis Optica Spectrum Disorder
Dean M. Wingerchuk, Claudia F. Lucchinetti
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Impact of comorbid Sjogren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders
Tetsuya Akaishi, Toshiyuki Takahashi, Kazuo Fujihara, Tatsuro Misu, Juichi Fujimori, Yoshiki Takai, Shuhei Nishiyama, Michiaki Abe, Tadashi Ishii, Masashi Aoki, Ichiro Nakashima
JOURNAL OF NEUROLOGY (2021)
Anti-aquaporin 4 IgG Is Not Associated With Any Clinical Disease Characteristics in Neuromyelitis Optica Spectrum Disorder
Oliver Schmetzer, Elisa Lakin, Ben Roediger, Ankelien Duchow, Susanna Asseyer, Friedemann Paul, Nadja Siebert
FRONTIERS IN NEUROLOGY (2021)
Immunobiology of neuromyelitis optica spectrum disorders
Daissy Liliana Mora Cuervo, Gisele Hansel, Douglas Kazutoshi Sato
CURRENT OPINION IN NEUROBIOLOGY (2022)
Discontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies (vol 8, e947, 2021)
Su-Hyun Kim, Hyunmin Jang, Na Young Park, Yeseul Kim, So-Yeon Kim, Min Young Lee, Jae-Won Hyun, Ho Jin Kim
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders
Valentina Damato, Jakob Theorell, Adam Al-Diwani, Anne-Kathrin Kienzler, Mateusz Makuch, Bo Sun, Adam Handel, Deniz Akdeniz, Antonio Berretta, Sudarshini Ramanathan, Andrew Fower, Daniel Whittam, Emily Gibbons, Nicholas McGlashan, Edward Green, Saif Huda, Mark Woodhall, Jacqueline Palace, Fintan Sheerin, Patrick Waters, Maria Leite, Anu Jacob, Sarosh R. Irani
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Neuromyelitis Optica Spectrum Disorder With Anti-Aquaporin-4 Antibody: Outcome Prediction Models
Liang Wang, Lei Du, Qinying Li, Fang Li, Bei Wang, Yuanqi Zhao, Qiang Meng, Wenyu Li, Juyuan Pan, Junhui Xia, Shitao Wu, Jie Yang, Heng Li, Jianhua Ma, Jingzi ZhangBao, Wenjuan Huang, Xuechun Chang, Hongmei Tan, Jian Yu, Lei Zhou, Chuanzhen Lu, Min Wang, Qiang Dong, Jiahong Lu, Chongbo Zhao, Chao Quan
FRONTIERS IN IMMUNOLOGY (2022)
Pathogenic antibodies to AQP4: Neuromyelitis optica spectrum disorder (NMOSD)
Sukhvir K. Wright, Evangeline Wassmer, Angela Vincent
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2021)
Optic neuritis after ocular trauma in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
Tetsuya Akaishi, Noriko Himori, Takayuki Takeshita, Kazuo Fujihara, Tatsuro Misu, Toshiyuki Takahashi, Juichi Fujimori, Tadashi Ishii, Masashi Aoki, Toru Nakazawa, Ichiro Nakashima
BRAIN AND BEHAVIOR (2021)
Treatment of Neuromyelitis Optica Spectrum Disorders
Koon-Ho Chan, Chi-Yan Lee
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Aquaporin 4-positive neuromyelitis optica spectrum disorder with meningoencephalitis-like onset: A case report
Yi Bu, Heng Liu, XuDong Qian, Fan Sun, ChengBo Li, Jingzhe Han
FRONTIERS IN IMMUNOLOGY (2022)
The Emerging Role of Microglia in Neuromyelitis Optica
Tingjun Chen, Dale B. Bosco, Yanlu Ying, Dai-Shi Tian, Long-Jun Wu
FRONTIERS IN IMMUNOLOGY (2021)
Foveal changes in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder are independent of optic neuritis and not overtly progressive
Adriana Roca-Fernandez, Frederike Cosima Oertel, Tianrong Yeo, Sedamirhosein Motamedi, Fay Probert, Matthew J. Craner, Jaume Sastre-Garriga, Hanna G. Zimmermann, Susanna Asseyer, Joseph Kuchling, Judith Bellmann-Strobl, Klemens Ruprecht, Maria Isabel Leite, Friedemann Paul, Alexander Ulrich Brandt, Jacqueline Palace
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Early Treatment Initiation With Oral Prednisolone for Relapse Prevention Alleviates Depression and Fatigue in Aquaporin-4-Positive Neuromyelitis optica Spectrum Disorder
Tetsuya Akaishi, Toshiyuki Takahashi, Kazuo Fujihara, Tatsuro Misu, Juichi Fujimori, Yoshiki Takai, Shuhei Nishiyama, Michiaki Abe, Tadashi Ishii, Masashi Aoki, Ichiro Nakashima
FRONTIERS IN NEUROLOGY (2021)
COVID-19 therapeutics: Challenges and directions for the future
Philip C. Robinson, David F. L. Liew, Helen L. Tanner, John R. Grainger, Raymond A. Dwek, Ronald B. Reisler, Lawrence Steinman, Marc Feldmann, Ling-Pei Ho, Tracy Hussell, Paul Moss, Duncan Richards, Nicole Zitzmann
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Mobilization of innate and adaptive antitumor immune responses by the RNP-targeting antibody ATRC-101
Alexander Scholz, Jeff DeFalco, Yvonne Leung, Iraz T. Aydin, Cathrin J. Czupalla, Wei Cao, Daniel Santos, Nikhil Vad, Shaun M. Lippow, Gilson Baia, Michael Harbell, Judevin Sapugay, Danhui Zhang, Dai-Chen Wu, Erin Wechsler, Anne Z. Ye, Jenny W. Wu, Xiao Peng, John Vivian, Hargita Kaplan, Rodney Collins, Ngan Nguyen, Mark Whidden, Dongkyoon Kim, Carl Millward, Jonathan Benjamin, Norman M. Greenberg, Tito A. Serafini, Daniel E. Emerling, Lawrence Steinman, William H. Robinson, Amy Manning-Bog
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis
Bao Ying Chen, Jessica R. Salas, Alyssa O. Trias, Arely Perez Rodriguez, Jonathan E. Tsang, Miriam Guemes, Thuc M. Le, Zoran Galic, H. Michael Shepard, Lawrence Steinman, David A. Nathanson, Johannes Czernin, Owen N. Witte, Caius G. Radu, Kenneth A. Schultz, Peter M. Clark
IMMUNOLOGY (2023)
Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder From the National Multiple Sclerosis Society Case Conference Proceedings
Carolyn Goldschmidt, Steven L. Galetta, Robert P. Lisak, Laura J. Balcer, Andrew Hellman, Michael K. Racke, Amy E. Lovett-Racke, Roberto Cruz, Matthew S. Parsons, Neda Sattarnezhad, Lawrence Steinman, Scott S. Zamvil, Elliot M. Frohman, Teresa C. Frohman
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2023)
Experimental encephalomyelitis at age 90, still relevant and elucidating how viruses trigger disease
Lawrence Steinman, Roberto Patarca, William Haseltine
JOURNAL OF EXPERIMENTAL MEDICINE (2023)
T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity
Sharon A. Sagan, Zahra Moinfar, Carson E. Moseley, Ravi Dandekar, Collin M. Spencer, Alan S. Verkman, Ole Petter Ottersen, Raymond A. Sobel, John Sidney, Alessandro Sette, Mark S. Anderson, Lawrence Steinman, Michael R. Wilson, Joseph J. Sabatino, Scott S. Zamvil
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)
Elevated α5 integrin expression on myeloid cells in motor areas in amyotrophic lateral sclerosis is a therapeutic target
Aude Chiot, Shanu F. Roemer, Lisa Ryner, Alina Bogachuk, Katie Emberley, Dillon Brownell, Gisselle A. Jimenez, Michael Leviten, Randall Woltjer, Dennis W. Dickson, Lawrence Steinman, Bahareh Ajami
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)
Roadmap for understanding mechanisms on how Epstein-Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trials
Tobias Lanz, William H. Robinson, Peggy P. Ho, Lawrence Steinman
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2023)
Update on Hepatic Safety of Ozanimod in Relapsing Multiple Sclerosis in the DAYBREAK Open-Label Extension Trial
K. W. Selmaj, L. Steinman, G. Comi, A. Bar-Or, H. P. Hartung, X. Montalban, E. K. Havrdova, J. K. Sheffield, A. Thorpe, J. V. Riolo, A. Krakovich, C. Y. Cheng, L. Kappos, J. A. Cohen, B. A. C. Cree
EUROPEAN JOURNAL OF NEUROLOGY (2023)
Disease Outcomes With Ublituximab in Participants With Highly Active Disease: Subpopulation Analyses of the Phase 3 ULTIMATE I and II Studies in Participants With Relapsing Multiple Sclerosis
Enrique Alvarez, Lawrence Steinman, Hans-Peter Hartung, Edward Fox, Peiqing Qian, Sibyl Wray, Derrick Robertson, Koby Mok, Christopher A. Garner, Bruce Cree
NEUROLOGY (2023)
Ublituximab Efficacy in Treatment-Naive Participants With Relapsing Multiple Sclerosis in the Phase 3 ULTIMATE I and II Studies
Lawrence Steinman, Edward Fox, Hans-Peter Hartung, Enrique Alvarez, Peiqing Qian, Sibyl Wray, Derrick Robertson, Deren Huang, Krzysztof Selmaj, Daniel Wynn, Jenna Bosco, Koby Mok, Christopher A. Garner, Bruce Cree
NEUROLOGY (2023)
Long-term Safety and Tolerability of Ozanimod by Age Category in Patients With Relapsing Multiple Sclerosis From Two Phase 3 Trials and an Open-Label Extension Study
K. W. Selmaj, J. A. Cohen, L. Steinman, G. Comi, A. Bar-Or, H. Hartung, X. Montalban, L. Kappos, J. K. Sheffield, A. Krakovich, C. Cheng, J. Riolo, D. Silva, B. A. Cree
MULTIPLE SCLEROSIS JOURNAL (2023)
Long-term Efficacy of Ozanimod by Age Category in Patients With Relapsing Multiple Sclerosis in Two Phase 3 Trials and an Open-label Extension Trial
B. A. Cree, K. Selmaj, L. Steinman, G. Comi, A. Bar-Or, D. L. Arnold, H. Hartung, X. Montalban, E. K. Havrdova, J. K. Sheffield, C. Cheng, J. V. Riolo, D. Silva, L. Kappos, J. A. Cohen
MULTIPLE SCLEROSIS JOURNAL (2023)
The B Cell Repertoire in Multiple Sclerosis Reveals Molecular Mimicry between EBV EBNA1 and GlialCAM
T. V. Lanz, R. C. Brewer, P. P. Ho, L. Steinman, W. H. Robinson
MULTIPLE SCLEROSIS JOURNAL (2023)
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: interim analysis of the DAYBREAK open-label extension study
K. W. Selmaj, L. Steinman, G. Comi, A. Bar-Or, D. L. Arnold, H. -P. Hartung, X. Montalban, E. K. Havrdova, A. Krakovich, J. K. Sheffield, C. -Y. Cheng, N. Minton, D. Silva, L. Kappos, J. A. Cohen, B. A. C. Cree
MULTIPLE SCLEROSIS JOURNAL (2022)